Literature DB >> 33441576

Preoperative predictive factor analysis of ovarian malignant involvement in premenopausal patients with clinical stage I endometrioid endometrial carcinoma.

Qin Chen1, Yan Feng2, Wenwen Wang1, Weiguo Lv2,3, Baohua Li4,5.   

Abstract

Earlier literature suggests that ovarian preservation in young premenopausal clinical stage I endometrioid endometrial carcinoma patients does not negatively impact prognosis. The main purpose of this study was to clarify the incidence of ovarian malignant involvement in this group and further identify potential preoperative predictive factors of ovarian malignant involvement. A total of 511 premenopausal (age ≤ 50 years) patients were enrolled for the study at Women's Hospital, Zhejiang University School of Medicine, between January 2002 and December 2016. Ovarian malignant involvements were detected in 23 of the patients (4.5%). Univariate and multivariate logistic analysis validated preoperative imaging of myometrial invasion depth and preoperative serum carbohydrate antigen 125 (CA125) level as independent risk predictors of postoperative ovarian malignant involvement. Receiver operating characteristic (ROC) curves was generated for a combination of the two factors. The area under curve (AUC) was 0.772 (95% confidence interval [CI] 0.661-0.884) for the combined two factors. The incidence of postoperative ovarian malignant involvement was relatively minimal. Preoperative imaging of myometrial invasion depth and serum CA125 level were independent risk predictors of ovarian malignant involvement. These findings may facilitate preoperative counseling of patients and informed clinical decision-making on ovarian preservation in these patients.

Entities:  

Year:  2021        PMID: 33441576      PMCID: PMC7806745          DOI: 10.1038/s41598-020-78953-4

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  27 in total

1.  Outcomes of ovarian preservation in a cohort of premenopausal women with early-stage endometrial cancer: a Korean Gynecologic Oncology Group study.

Authors:  Taek Sang Lee; Jung-Yun Lee; Jae-Weon Kim; Sohee Oh; Seok Ju Seong; Jong Min Lee; Tae Jin Kim; Chi Heum Cho; Seok-Mo Kim; Chan-Yong Park
Journal:  Gynecol Oncol       Date:  2013-08-29       Impact factor: 5.482

2.  Risk factors for ovarian involvement in young and premenopausal endometrioid endometrial cancer patients.

Authors:  Jun Li; Qin Zhu; Bingyi Yang; Chengcheng Ning; Xiaoxia Liu; Xuezhen Luo; Xiaojun Chen
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2018-01-31       Impact factor: 2.435

Review 3.  Revised FIGO staging system for endometrial cancer.

Authors:  Sharyn N Lewin
Journal:  Clin Obstet Gynecol       Date:  2011-06       Impact factor: 2.190

Review 4.  Risk factors for endometrial cancer: An umbrella review of the literature.

Authors:  Olivia Raglan; Ilkka Kalliala; Georgios Markozannes; Sofia Cividini; Marc J Gunter; Jaya Nautiyal; Hani Gabra; Evangelos Paraskevaidis; Pierre Martin-Hirsch; Kostas K Tsilidis; Maria Kyrgiou
Journal:  Int J Cancer       Date:  2019-02-20       Impact factor: 7.396

5.  Feasibility of ovarian preservation in patients with early stage endometrial carcinoma.

Authors:  Taek Sang Lee; Ji Ye Jung; Jae Weon Kim; Noh-Hyun Park; Yong-Sang Song; Soon-Beom Kang; Hyo-Pyo Lee
Journal:  Gynecol Oncol       Date:  2006-08-02       Impact factor: 5.482

6.  Risk factors for young premenopausal women with endometrial cancer.

Authors:  Pamela T Soliman; Jonathan C Oh; Kathleen M Schmeler; Charlotte C Sun; Brian M Slomovitz; David M Gershenson; Thomas W Burke; Karen H Lu
Journal:  Obstet Gynecol       Date:  2005-03       Impact factor: 7.661

7.  Metastatic and independent cancers of the endometrium and ovary: a clinicopathologic study of 34 cases.

Authors:  T M Ulbright; L M Roth
Journal:  Hum Pathol       Date:  1985-01       Impact factor: 3.466

8.  Safety of ovarian preservation in premenopausal women with endometrial cancer.

Authors:  Jason D Wright; Adam M Buck; Monjri Shah; William M Burke; Peter B Schiff; Thomas J Herzog
Journal:  J Clin Oncol       Date:  2009-01-26       Impact factor: 44.544

Review 9.  Synchronous tumours of the female reproductive tract.

Authors:  C Blake Gilks; Friedrich Kommoss
Journal:  Pathology       Date:  2017-12-14       Impact factor: 5.306

10.  Prognosis of women with stage I endometrioid endometrial cancer and synchronous stage I endometrioid ovarian cancer.

Authors:  Koji Matsuo; Hiroko Machida; Marina Frimer; Jenna Z Marcus; Tanja Pejovic; Lynda D Roman; Jason D Wright
Journal:  Gynecol Oncol       Date:  2017-10-04       Impact factor: 5.482

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.